Theriva Biologics, Inc. (TOVX) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Patients Treated with Zabilugene Almadenorepvec to Date | 142.00 | FY2026-Q2 |
Back to TOVX overview · TOVX earnings · TOVX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.